Comparative Study
doi: 10.1159/000468286.
Clinical and social comparison of fluphenazine decanoate and flupenthixol decanoate in the community maintenance therapy of schizophrenia
- PMID: 406212
- DOI: 10.1159/000468286
Item in Clipboard
Comparative Study
Clinical and social comparison of fluphenazine decanoate and flupenthixol decanoate in the community maintenance therapy of schizophrenia
Int Pharmacopsychiatry.
1977.
Abstract
The clinical and social effects of flupenthixol decanoate and fluphenazine decanoate were compared in the maintenance treatment of a population of chronic schizophrenic out-patients over a period of 9 months. The results failed to show significant difference between the treatments, and in particular, reports suggesting specific advantages for flupenthixol decanoate in alleviating the negative symptoms of apathy, anergia and depression in chronic schizophrenics were not confirmed. It seems that chronic schizophrenic patients who are well established on one depot preparation are unlikely to be benefited by being changed to the alternative.
Similar articles
-
A double-blind comparison of flupenthixol decanoate and fluphenazine decanoate in the treatment of chronic schizophrenia.Acta Psychiatr Scand. 1979 Oct;60(4):313-22. doi: 10.1111/j.1600-0447.1979.tb00281.x. Acta Psychiatr Scand. 1979. PMID: 390972 Clinical Trial.
-
An open clinical trial with the long-acting neuroleptics flupenthixol decanoate and fluphenazine decanoate in the maintenance treatment of schizophrenia.Pharmatherapeutica. 1989;5(6):371-9. Pharmatherapeutica. 1989. PMID: 2687894 Clinical Trial.
-
Depressive and extrapyramidal symptoms and clinical effects: a trial of fluphenazine versus flupenthixol in maintenance of schizophrenic out-patients.Br J Psychiatry. 1979 Dec;135:515-23. doi: 10.1192/bjp.135.6.515. Br J Psychiatry. 1979. PMID: 394794 Clinical Trial.
-
Comparative double-blind study of flupenthixol decanoate and fluphenazine decanoate in the treatment of patients relapsing in a schizophrenic symptomatology.Acta Psychiatr Scand. 1983 Jun;67(6):378-88. doi: 10.1111/j.1600-0447.1983.tb09718.x. Acta Psychiatr Scand. 1983. PMID: 6349256 Clinical Trial.
-
[Current status of neuroleptic long term treatment of schizophrenia].Nervenarzt. 1975 Nov;46(11):611-6. Nervenarzt. 1975. PMID: 813157 Review. German. No abstract available.
Cited by
-
Flupenthixol decanoate (depot) for schizophrenia or other similar psychotic disorders.Cochrane Database Syst Rev. 2014 Jun 10;2014(6):CD001470. doi: 10.1002/14651858.CD001470.pub2. Cochrane Database Syst Rev. 2014. PMID: 24915451 Free PMC article.
-
Oral and long-acting antipsychotics for relapse prevention in schizophrenia-spectrum disorders: a network meta-analysis of 92 randomized trials including 22,645 participants.World Psychiatry. 2022 Jun;21(2):295-307. doi: 10.1002/wps.20972. World Psychiatry. 2022. PMID: 35524620 Free PMC article.
-
Estimating the optimal dose of flupentixol decanoate in the maintenance treatment of schizophrenia-a systematic review of the literature.Psychopharmacology (Berl). 2019 Nov;236(11):3081-3092. doi: 10.1007/s00213-019-05311-2. Epub 2019 Jul 12. Psychopharmacology (Berl). 2019. PMID: 31300829 Free PMC article.
-
Fluphenazine decanoate (depot) and enanthate for schizophrenia.Cochrane Database Syst Rev. 2015 Feb 5;2015(2):CD000307. doi: 10.1002/14651858.CD000307.pub2. Cochrane Database Syst Rev. 2015. PMID: 25654768 Free PMC article.